Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer

NCT03697564 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Stage IV

Interventions

DRUG: Gemcitabine
DRUG: Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
DRUG: Cabiralizumab

Sponsor

Hitendra Patel

Collaborators

[object Object]
[object Object]